Synthesis of chalcone incorporated quinazoline derivatives as anticancer agents

Abstract

A series of ten novel chalcone incorporated quinazoline derivatives (11a–11j) were designed and synthesized. All the synthesized compounds were evaluated for their anticancer activities against four human cancer cell lines (A549, HT-29, MCF-7 and A375). Among them, four compounds, 11f, 11g, 11i and 11j showed more potent anticancer activity than the control drug, Combretastatin – A4.

Keywords

• Gefitinib
• Erlotinib
• Resveratrol
• Chalcones
• Quinazolines
• Cytotoxicity